Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Finalists Named In University Spin-out AwardsThe world’s first wireless sensor for sleeping and breathing and silicone contact lenses for glaucoma patients are finalists for first European awards for university entrepreneurs.
By: Terri Robinson Bjorgan LONDON – 12 November, 2008 – Andrew Lynn from the University of Cambridge and Conor Hanley from University College Dublin, are among 24 entrepreneurs named as finalists in Europe’s first pan-European awards for researchers who start businesses. A selection committee of leading industry officials and academics, met at University College London, and selected the entrepreneurs from nominations across Europe. The 24 finalists will go through to the final round of judging, by the Science|Business Innovation Board, in Stockholm on 2 December. The high quality of finalists, from such European research universities as University of Oxford and Karolinska Institutet, underscores the abilities of Europe’s research sector at finding creative ways to get their discoveries out of the lab and into the marketplace. The finalists are grouped in six categories, by industry sector and type of entrepreneur. One category, the Bridge Award, is for an individual who has done the most to promote good industry-academic relations. Finalists for that are Tom Hockaday, ISIS Innovation, Eleanor Taylor, Scottish Enterprise and Hans Wigzell, from Karolinksa Institutet. The finalists were chosen by a selection committee which included representatives of the 27 universities and research institutes supporting the programme, including UCL, Karolinska Institutet in Stockholm, ETH-Zurich, INSEAD and Imperial College London. The final judging will take place in Stockholm on Dec. 2, by the Science|Business Innovation Board, a blue-ribbon panel of leaders in industry, academia and policy. Members include Esko Aho, former Finnish prime minister; J. Frank Brown, Dean of INSEAD; Jean-Philippe Courtois, President of Microsoft International, and Harriet Wallberg-Henriksson, president of Karolinska, the Swedish university that names the Nobel Prize in Medicine or Physiology each year. The finalists will attend a conference on academic enterprise at Karolinska, and a gala awards dinner at the Swedish Royal Academy of Engineering. The awards programme was begun by the London-based Science|Business Innovation Board. Sponsors include Microsoft, Procter & Gamble, Vinnova, Amgen, Johnson & Johnson Pharmaceutical Research & Development, the Swedish Royal Academy of Engineering, the Wellcome Trust, and CEFIC, the European Chemical Industry Council. In addition, supporters of the Investment Connection, an online interchange between nominees and potential investors, include law firm Wilmer Hale. Media sponsors are the Wall Street Journal Europe and Technology Review magazine. FULL LIST OF FINALISTS IN EACH CATEGORY: Chemistry/Materials *Brian Hayden: Ilika Technologies Ltd., UK Ideas developed at University of Southampton, UK *Andrew Lynn : Orthomimetics Ltd., UK Ideas developed at The University of Cambridge, UK *Mark Moloney, Jon-Paul Griffiths, Marcelo Bravo: Oxford Advances Surfaces Group Plc, UK Ideas developed at The University of Oxford, UK Energy/Environment *Colin Hills, Paula Carey, Stefan Simons: Carbon8 Biogas Ltd., UK Ideas developed at The University of Greenwich, UK *Adel Sharif: Surrey Aquatechnology Limited (Modern Water), UK Ideas developed at The University of Surrey, UK *Tiancun Xiao and Malcolm Green: Oxford Catalysts, UK Ideas developed at The University of Oxford’s prestigious Wolfson Catalysis Centre, UK ICT *Peter Andrekson and Mathias Westlund: Picosolve, Sweden Ideas developed at Chalmers University of Technology, Sweden *Pasquale Pigazzini, Augusto Sarti, Stefano Tubaro: Kee Square SRL, Italy Ideas developed at Dipartimento di Elettronica e Informazione, Politecnico di Milano, Italy *Stefan Tuchschmid:VirtaMed AG, Switzerland Ideas developed at the Department of Information Technology and Electrical Engineering, ETH- Zürich, Switzerland Life Sciences *Conor Hanley: Biancamed Ltd, Ireland Ideas developed at University College Dublin, Ireland *Matteo Leonardi: Sensimed SG, Switzerland Ideas developed at Microsystem integration laboratory/EPFL, Switzerland *Neville H McClenaghan, Peter R Flatt, Finbarr PM O’Harte: Diabetica Limited, UK Ideas developed at The University of Ulster, UK The Fast Start *Colin Hills, Paula Carey, Stefan Simons: Carbon8 Biogas Ltd., UK Ideas developed at The University of Greenwich, UK *Pasquale Pigazzini, Augusto Sarti, Stefano Tubaro: Kee Square SRL, Italy Ideas developed at Dipartimento di Elettronica e Informazione, Politecnico di Milano, Italy *Gandert Van Raemdonck, Hjalmar Van Raemdonck: Ephicas bv, The Netherlands Ideas developed at: TU Delft, The Netherlands The Bridge Award *Tom Hockaday, ISIS Innovation, UK *Eleanor Taylor, Scottish Enterprise, UK *Hans Wigzell, Karolinska Institutet, Sweden **** For more information about the ACES Awards and to enter, visit www.sciencebusiness.net/ SELECTION COMMITTEE FOR THE ACES AWARDS: Iordanis Arzimanoglou, CEO Thessaloniki Innovation Zone, Aristotle University Silvio Bonaccio, Head of Transfer, ETH - Swiss Federal Institute of Technology Zurich Neil Bradshaw, Director of Enterprise, University of Bristol Johan Carlsten, Vice President, Chalmers University of Technology Anthony Clarke, Managing Director, GLE Growth Capital - comprising London Business Angels and London Seed Capital; Main Board Director of GLE Group Dr Malcolm Cross, Director of Bath Ventures, University of Bath Sylvain Gilat, Head, Communications & Global Advancement, ESPCI ParisTech Hermann Hauser, Chairman, Amadeus Capital Partners Tom Hockaday, Managing Director, Isis Innovation Dr. Elena Lurie-Luke, Director of Global BioScience Business Development, Procter & Gamble John Mihell, Business Development Manager, University of Warwick Joe Pillman, Chair, UK Corporate Practice, WilmerHale Julia Prats, Head of the Entrepreneurship Department, IESE Business School, University of Navarra Tony Raven, Director Research & Innovation Services, Southampton University Mike Spyer, Vice-Provost (Enterprise) Carl J. Sundberg, MD, PhD, MD, PhD, University Lecturer, Associate Professor Coordinator Science & Society at the President's office Karolinska Institutet; Dpt of Physiology & Pharmacology/ Gianluca Valentini, Professor, Politecnico di Milano Koen Vanhoutte, PhD, Director Pharmaceutical Sciences, J&J PRD Jordi Vinaixa, Associate Professor of Entrepreneurship, ESADE Business School Colin Wyatt, Business Development Director, Imperial College London SCIENCE BUSINESS INNOVATION BOARD: Esko Aho, President, Finnish innovation fund SITRA, and former prime minister of Finland Jean-Philippe Courtois, President, Microsoft International Pat Cox, President, European Movement, and former President of the European Parliament Roch Doliveux, CEO and Chairman, UCB Denis Payre, Co-founder, Business Objects, and CEO, Kiala Philippe Pouletty, General Partner, Truffle Ventures, and Chairman, France Biotech Alfons Sauquet, Dean, ESADE Business School Helmut Schühsler, Managing Partner, TVM Capital Harriet Wallberg-Henriksson, President, Karolinska Institutet Founding University Supporters: Aristotle University of Thessaloniki Chalmers University of Technology ETH-Zürich Imperial College London INSEAD Isis Innovation, University of Oxford Karolinska Institutet NTNU – Norwegian Science and Technology University ParisTech Politecnico di Milano SetSquared Partnership (Universities of Bath, Bristol, Southampton and Surrey) TU Delft UCL - University College London University of Warwick For further information, contact: Terri Robinson Bjørgan Science|Business +32 2 514 6680 terri.robinson@ www.sciencebusiness.net # # # About Science Business: Science|Business is an independent news and events service for early-stage investment in R&D, across Europe, across industries. Drawing on a network of leading journalists and scientific institutions, www.sciencebusiness.net reports on the first wave of technology - licensing, spin-off investment, intellectual property, contract research and corporate R&D management. Its aim: to bridge the gap between academia and industry in Europe. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||
